...
首页> 外文期刊>Case Reports in Hepatology >Development of Hepatocellular Carcinoma in a Patient with Chronic Hepatitis C 21 Years after Achieving a Sustained Virological Response to Interferon Therapy
【24h】

Development of Hepatocellular Carcinoma in a Patient with Chronic Hepatitis C 21 Years after Achieving a Sustained Virological Response to Interferon Therapy

机译:慢性丙型肝炎患者肝细胞癌21岁以达到干扰素治疗的持续病毒学反应后的肝细胞癌

获取原文
           

摘要

A 77-year-old man with chronic hepatitis C (CH-C) infection, who achieved a sustained virological response (SVR) to interferon (IFN) therapy, was followed up regularly. Before IFN therapy, he did not have metabolic diseases, and the histological diagnosis of his chronic hepatitis was stage-3 fibrosis. After achieving SVR, the fibrosis-4 (FIB-4) index level dropped once but gradually increased. 21 years after SVR, hepatocellular carcinoma (HCC) was diagnosed by dynamic computed tomography. The HCC was 12?mm in diameter. The HCC was treated with radiofrequency ablation. CH-C patients with advanced fibrosis require long-term follow-up, even after achieving SVR.
机译:一名77岁男性,含有慢性丙型肝炎(CH-C)感染,他经常达到干扰素(IFN)治疗的持续病毒学反应(SVR)。在IFN治疗之前,他没有代谢疾病,他的慢性肝炎的组织学诊断是第3阶段3纤维化。在实现SVR后,纤维化-4(FIB-4)指数水平逐渐降低但逐渐增加。 21年后SVR后,通过动态计算断层扫描诊断肝细胞癌(HCC)。 HCC直径为12?mm。 HCC被射频消融治疗。即使在实现SVR后,CH-C患有先进的纤维化患者需要长期随访。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号